Skip to main content

China’s Sinovac vaccine ‘inadequate’ against omicron variant, study finds

One of the most widely used vaccines in the world, the COVID vaccine developed by China's Sinovac, has shown no neutralizing antibodies in a small Hong Kong study.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.